About Zyden Gentec Limited
Data last updated:
Zyden Gentec Limited is a public limited company based in Kota, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 April 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN L67120RJ1994PLC008284. Its GSTIN is 08AAACZ2189G1Z3 (Rajasthan). The company holds 2 GST registrations, of which 1 is active. It is recorded as listed by MCA, but its shares were delisted from BSE on 23 Nov 2023 · compulsory delisting, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.11 Cr. It is led by directors including Anita Kumari and Niranjan Kumar Agrawal.
Its last annual general meeting (AGM) was held on 28 September 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 143 Deepshri Building Kotri Road Gumanpura, Kota, Rajasthan, India – 324007.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.18 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹8.8 Cr and EBITDA of -₹8.76 Cr. Revenue has declined at a compounded annual rate (CAGR) of 40% over three years and 56% over five years.
The company is associated with 1 brand: Zyden Gentec. As per MCA filings, the company has open charges of ₹13.73 Cr and satisfied charges of ₹2.37 Cr on record. Court records list 19 cases involving the company, including 13 filed by the company and 6 filed against it; 1 case is pending. The company has 112 deals on record (112 market trades); the latest was in February 2015. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Salvavidas Industries Private Limited with revenue of ₹1.21 Lakh.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website zydengentec.com.
Company details
Contact details
Zyden Gentec Limited's registered office is in Kota, Rajasthan. Its website is zydengentec.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address143 Deepshri Building Kotri Road Gumanpura, Kota, Rajasthan, India – 324007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zyden Gentec Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Zyden Gentec operates one associated brand: Zyden Gentec. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Blog focusing on mortgage, refinance, penny stock, and other related topics | zydengentec.com |
Financials of Zyden Gentec Limited
FY 2020 filings availableZyden Gentec Limited reported revenue of ₹1.18 Lakh (down 99% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 56% over five years, including a 99% fall in the latest year. EBITDA fell 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zyden Gentec Limited, buy the company report.
Board of directors of Zyden Gentec Limited
Zyden Gentec has 3 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Kumari | Director | 31 Mar 2015 | 11 Years 7 Months | Current |
| Niranjan Kumar Agrawal | Director | 28 Jan 2004 | 22 Years 9 Months | Current |
| Manoj Kumar Also directs: Sharda Advisory Services Private Limited | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Zyden Gentec Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Salvavidas Industries Private Limited | ₹1.21 Lakh (FY 2025) | Surat, Gujarat, India | ||||
| Tulips Medicaments Pvt Ltd | ₹1.2 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Novello Medica Private Limited | ₹1.2 Lakh (FY 2025) | Dehradun, Uttarakhand, India | ||||
| Rouland Oxides Private Limited | ₹1.2 Lakh (FY 2024) | Telangana, India | ||||
| Sward Formulations Private Limited | ₹1.19 Lakh (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Zyden Gentec Limitedthis company | ₹1.18 Lakh (FY 2020) | -₹8.8 Cr | -99.0% | Kota, Rajasthan, India | ||
| Medhexia Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2021) | 2.0% | Gurgaon, Haryana, India | |||
| Pass (India) Private Limited | ₹1.17 Lakh (FY 2024) | 4.0% | Uttar Pradesh, India | |||
| Rynish Pharmaceuticals Private Limited | ₹1.17 Lakh (FY 2025) | -98.0% | Mumbai, Maharashtra, India | |||
| Health Pharmacy Private Limited | ₹1.16 Lakh (FY 2025) | 187.0% | Kolkata, West Bengal, India | |||
| Srinaas Chemicals and Pharmaceuticals Private Limited | ₹1.15 Lakh (FY 2024) | Bibinagar, Telangana, India |
To see the full peer comparison of Zyden Gentec Limited, buy the company report.
Auditor
Zyden Gentec Limited is audited by RAJVANSHI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJVANSHI & ASSOCIATES | FY 2019 | 005069C |
Shareholding
The shareholding of Zyden Gentec Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Zyden Gentec Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Mar 2012 | 10353396 | Punjab National Bank | ₹21.8 Lakh | Open | |
| 16 Mar 2012 | 10353747 | Punjab National Bank | ₹1 Cr | Open | |
| 08 Jul 2011 | 10299486 | Punjab National Bank | ₹44 Lakh | Open | |
| 29 Mar 2011 | 10281221 | Punjab National Bank | ₹4.75 Lakh | Open | |
| 29 Apr 2010 | 10218639 | Punjab National Bank | ₹3.35 Cr | Open |
To see the full charge records of Zyden Gentec Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Zyden Gentec Limited has 112 deals on record (112 market trades); the latest was in February 2015.
Deals on record (5 of 112)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2015 | Market trade | ₹8.3 Lakh | Buyer: Deepak Healthcare Private Limited , an individual Seller: Deepak Healthcare Private Limited , an individual |
| Jan 2015 | Market trade | ₹21.4 Lakh | Buyer: 2 individuals Seller: Deepak Healthcare Private Limited , 2 individuals |
| Jan 2015 | Market trade | ₹13.9 Lakh | Buyer: Deepak Healthcare Private Limited , 2 individuals Seller: Deepak Healthcare Private Limited , an individual |
| Nov 2014 | Market trade | ₹43.8 Lakh | Buyer: Ridhisidhi Financial Advisory Private Limited , Splendour Portfolio Private Limited , an individual Seller: an individual |
| Sep 2014 | Market trade | ₹27.7 Lakh | Buyer: an individual Seller: Arcadia Share and Stock Brokers Private Limited , an individual |
To see the full deal history of Zyden Gentec Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Zyden Gentec Limited has 19 court cases on record: 13 filed by Zyden Gentec, 6 filed against it. 1 case is pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 2 | 1 |
| District courts | 3 | 2 | 0 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by Camlin Fine Sciences Ltd | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| High Court, TELANGANA | Appeal | Filed against the company by an individual | Disposed |
| High Court | Writ petition | Filed by the company against individuals | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against State of Raj and Ors | Disposed |
To see the full case history of Zyden Gentec Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zyden Gentec Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zyden Gentec has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACZ2189G1Z3 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zyden Gentec Limited, buy the company report.
Recent activity
Zyden Gentec Limited has 18 board changes on record since 2004: 3 appointments and 15 cessations. The latest: Vaibhav Singh ceased to be Director on 03 May 2022.
26 earlier events are in the company report.
Frequently asked questions
Zyden Gentec is an active public limited company based in Kota, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 April 1994 (32+ years old) and is registered under CIN L67120RJ1994PLC008284.
Zyden Gentec has 3 current directors:
- Anita Kumari - Director
- Niranjan Kumar Agrawal - Director
- Manoj Kumar - Director
The latest financial statements of Zyden Gentec on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 28 September 2020. Year-wise statements from 2015 are in the company report.
The GSTIN of Zyden Gentec is 08AAACZ2189G1Z3, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Zyden Gentec is L67120RJ1994PLC008284. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zyden Gentec is recorded as a listed company by MCA, but its shares were delisted from BSE on 23 Nov 2023 · compulsory delisting, and no longer trade on a stock exchange.
Zyden Gentec has 19 court cases on record: 13 filed by the company and 6 filed against it. 1 is pending. Most are in the high courts.
Zyden Gentec was incorporated on 26 April 1994, making it 32+ years old. It is registered with the Registrar of Companies, Jaipur.
Zyden Gentec has 112 deals on record (112 market trades); the latest was in February 2015.
The peers of Zyden Gentec by revenue are Salvavidas Industries Private Limited, Tulips Medicaments Pvt Ltd, Novello Medica Private Limited, Rouland Oxides Private Limited, Sward Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Vaibhav Singh ceased to be Director on 03 May 2022. Vinod Shiv Kumar Gupta ceased to be Managing Director on 30 Sep 2020. Manoj Kumar was appointed as Director on 29 Sep 2018. Zyden Gentec has 18 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
